- Investigator
- Carmen Isache
- Ages
- N/A
- Sexes
- All
Clinical trials
-
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Investigate the Efficacy and Safety of Asapiprant in Hospitalized Adults With COVID-19 -
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Cutaneous Sarcoidosis - Ages
- 18 Years - 75 Years
- Sexes
- All
-
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis (20210052) - Investigator
- Vandana K Seeram
- Ages
- 40 Years - 99 Years
- Sexes
- All
-
蹤獲扦 JAX Hernia Outcomes Data Bank - Investigator
- Jana M Sacco
- Ages
- 18 Years - N/A
- Sexes
- All
-
The Connection study (20191002) - Investigators
- William R Driscoll, Mark Hudak, Ma Ingyinn, Orlyn C Lavilla, John W Logan, Dawn D McDaniel, Padma S Nandula, Shalinkumar P Patel, Sanket Shah, Renu Sharma, Winston T Sheen
- Ages
- N/A
- Sexes
- All
-
ABCD Gene Substudy - Investigator
- Francesco Franchi
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
AMPLITUDE - Investigator
- Dominick J Angiolillo
- Ages
- 18 Years - 65 Years
- Sexes
- All
-
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants with Active Systemic Lupus Erythematosus (SLE) - Investigator
- Gurjit S Kaeley
- Ages
- 18 Years - 75 Years
- Sexes
- All
-
The American Lung Association (ALA) Lung Health Cohort (LHC) - Investigator
- Vandana K Seeram
- Ages
- 25 Years - 35 Years
- Sexes
- All